Cargando…

Mapping Dermatology Life Quality Index (DLQI) scores to EQ-5D utility scores using data of patients with atopic dermatitis from the National Health and Wellness Study

PURPOSE: To develop a mapping algorithm for generating EQ-5D-5-level (EQ-5D-5L) utility scores from the Dermatology Life Quality Index (DLQI) in patients with atopic dermatitis (AD). METHODS: The algorithm was developed using data from 1232 patients from four countries participating in the National...

Descripción completa

Detalles Bibliográficos
Autores principales: Vilsbøll, Andreas Westh, Kragh, Nana, Hahn-Pedersen, Julie, Jensen, Cathrine Elgaard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434755/
https://www.ncbi.nlm.nih.gov/pubmed/32297132
http://dx.doi.org/10.1007/s11136-020-02499-1
_version_ 1783572201324150784
author Vilsbøll, Andreas Westh
Kragh, Nana
Hahn-Pedersen, Julie
Jensen, Cathrine Elgaard
author_facet Vilsbøll, Andreas Westh
Kragh, Nana
Hahn-Pedersen, Julie
Jensen, Cathrine Elgaard
author_sort Vilsbøll, Andreas Westh
collection PubMed
description PURPOSE: To develop a mapping algorithm for generating EQ-5D-5-level (EQ-5D-5L) utility scores from the Dermatology Life Quality Index (DLQI) in patients with atopic dermatitis (AD). METHODS: The algorithm was developed using data from 1232 patients from four countries participating in the National Health and Wellness Study. Spearman’s rank correlation coefficient was used to evaluate the conceptual overlap between DLQI and EQ-5D-5L. Six mapping models (ordinary least squares [OLS], Tobit, three different two-part models, and a regression mixture model) were tested with different specifications to determine model performance and were ranked based on the sum of mean absolute error (MAE), and root mean squared error (RMSE). RESULTS: The mean DLQI score was 7.23; mean EQ-5D-5L score was 0.78; and there were moderate negative correlations between DLQI and EQ-5D-5L scores (p = − 0.514). A regression mixture model with total DLQI, and age and sex as independent variables performed best for mapping DLQI to EQ-5D-5L (RMSE = 0.113; MAE = 0.079). CONCLUSION: This was the first study to map DLQI to EQ-5D-5L exclusively in patients with AD. The regression mixture model with total DLQI, and age and sex as independent variables was the best performing model and accurately predicted EQ-5D-5L. The results of this mapping can be used to translate DLQI data from clinical studies to health state utility values in economic evaluations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s11136-020-02499-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7434755
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-74347552020-08-24 Mapping Dermatology Life Quality Index (DLQI) scores to EQ-5D utility scores using data of patients with atopic dermatitis from the National Health and Wellness Study Vilsbøll, Andreas Westh Kragh, Nana Hahn-Pedersen, Julie Jensen, Cathrine Elgaard Qual Life Res Article PURPOSE: To develop a mapping algorithm for generating EQ-5D-5-level (EQ-5D-5L) utility scores from the Dermatology Life Quality Index (DLQI) in patients with atopic dermatitis (AD). METHODS: The algorithm was developed using data from 1232 patients from four countries participating in the National Health and Wellness Study. Spearman’s rank correlation coefficient was used to evaluate the conceptual overlap between DLQI and EQ-5D-5L. Six mapping models (ordinary least squares [OLS], Tobit, three different two-part models, and a regression mixture model) were tested with different specifications to determine model performance and were ranked based on the sum of mean absolute error (MAE), and root mean squared error (RMSE). RESULTS: The mean DLQI score was 7.23; mean EQ-5D-5L score was 0.78; and there were moderate negative correlations between DLQI and EQ-5D-5L scores (p = − 0.514). A regression mixture model with total DLQI, and age and sex as independent variables performed best for mapping DLQI to EQ-5D-5L (RMSE = 0.113; MAE = 0.079). CONCLUSION: This was the first study to map DLQI to EQ-5D-5L exclusively in patients with AD. The regression mixture model with total DLQI, and age and sex as independent variables was the best performing model and accurately predicted EQ-5D-5L. The results of this mapping can be used to translate DLQI data from clinical studies to health state utility values in economic evaluations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s11136-020-02499-1) contains supplementary material, which is available to authorized users. Springer International Publishing 2020-04-15 2020 /pmc/articles/PMC7434755/ /pubmed/32297132 http://dx.doi.org/10.1007/s11136-020-02499-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Vilsbøll, Andreas Westh
Kragh, Nana
Hahn-Pedersen, Julie
Jensen, Cathrine Elgaard
Mapping Dermatology Life Quality Index (DLQI) scores to EQ-5D utility scores using data of patients with atopic dermatitis from the National Health and Wellness Study
title Mapping Dermatology Life Quality Index (DLQI) scores to EQ-5D utility scores using data of patients with atopic dermatitis from the National Health and Wellness Study
title_full Mapping Dermatology Life Quality Index (DLQI) scores to EQ-5D utility scores using data of patients with atopic dermatitis from the National Health and Wellness Study
title_fullStr Mapping Dermatology Life Quality Index (DLQI) scores to EQ-5D utility scores using data of patients with atopic dermatitis from the National Health and Wellness Study
title_full_unstemmed Mapping Dermatology Life Quality Index (DLQI) scores to EQ-5D utility scores using data of patients with atopic dermatitis from the National Health and Wellness Study
title_short Mapping Dermatology Life Quality Index (DLQI) scores to EQ-5D utility scores using data of patients with atopic dermatitis from the National Health and Wellness Study
title_sort mapping dermatology life quality index (dlqi) scores to eq-5d utility scores using data of patients with atopic dermatitis from the national health and wellness study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434755/
https://www.ncbi.nlm.nih.gov/pubmed/32297132
http://dx.doi.org/10.1007/s11136-020-02499-1
work_keys_str_mv AT vilsbøllandreaswesth mappingdermatologylifequalityindexdlqiscorestoeq5dutilityscoresusingdataofpatientswithatopicdermatitisfromthenationalhealthandwellnessstudy
AT kraghnana mappingdermatologylifequalityindexdlqiscorestoeq5dutilityscoresusingdataofpatientswithatopicdermatitisfromthenationalhealthandwellnessstudy
AT hahnpedersenjulie mappingdermatologylifequalityindexdlqiscorestoeq5dutilityscoresusingdataofpatientswithatopicdermatitisfromthenationalhealthandwellnessstudy
AT jensencathrineelgaard mappingdermatologylifequalityindexdlqiscorestoeq5dutilityscoresusingdataofpatientswithatopicdermatitisfromthenationalhealthandwellnessstudy